Revvity Unveils New Automated Tuberculosis Testing Solution
Revvity launched the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test for latent tuberculosis infection detection.
Category: Tuberculosis
Tuberculosis
Latest
Tuberculosis
Latest
How AI Could Ease Hospital Pressures
Pioneering artificial intelligence (AI) which automatically diagnoses lung diseases could ease winter pressures on hospitals.
Tuberculosis
Latest
Thermo Fisher, NanoPin Collaborate to Develop Analytical Workflow for Infectious Disease Diagnosis and Patient Monitoring
NanoPin’s diagnostic platform using Thermo Fisher’s advanced LC-MS technology will create sensitive clinical assays for infectious disease.
Researchers Discover Causative Genetic Mutations in Patients with Familial Sarcoidosis
Study data show that the metabolic sensor mTOR contributes on the genetic level to the development of sarcoidosis.
Read More
Study Results Guide Anti-CMV Treatment after Stem Cell Transplantation
Continued validation of Lophius’ development capabilities bodes well as the company advances into tuberculosis diagnostics as its next focus area.
Read More
BD Launches Molecular Test for Tuberculosis
The BD Max MDR-TB panel has obtained the CE mark, supporting market launch in Europe.
Read More
Advancing Tuberculosis Testing
Protecting sample stability ensures the utility of the latest generation of TB tests.
Read More
TB Data-Sharing Platform Launches to Public
The analytic visualization tool can be used to discover, grade, and track key bacterial drug-resistance mutations.
Read More
Study Confirms Blood Test as Predictor of Tuberculosis Risk
The landmark NIH study represents a major advance in tuberculosis research.
Read MoreUSAID, Cepheid Join Forces to Battle Multidrug-Resistant Tuberculosis
Cepheid has signed a memorandum of understanding representing its intention to work with USAID to support the White House’s national action plan for combating MDR-TB.
Read More
Critical Path Institute Receives Grant to Accelerate Tuberculosis Diagnostics
A multiyear grant from the Bill & Melinda Gates Foundation will fund an innovative global data platform designed to streamline tuberculosis diagnosis and treatment.
Read More
FDA Approves Cepheid’s Rapid TB Test
Results are available to clinicians in approximately 2 hours.
Read More
NanoLogix Rapid TB Detection Results Published In Journal
Third-party R&D lab achieves 5-day tuberculosis detection, compared to weeks for standard tests.
Read MoreNEJM Reports Xpert MTB/RIF Faster, Sensitive & Specific Test for TB
Cepheid announced that its Xpert MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), “Rapid Molecular Detection of Tuberculosis and Rifampin Resistance.”
Read MoreNew Blood-Based Genomic Marker for Tuberculosis May Help ID Future Patients
It may soon be possible to identify patients who will develop tuberculosis, as scientists have identified changes in the blood specific to the disease.
Read MoreSeegene Introduces Real-time Molecular Diagnostic Test for Tuberculosis
Seegene introduced Anyplex MDR-TB Screening Test, the first real-time PCR molecular diagnostic capable of simultaneous detection of TB and genetic mutations leading to multi-drug resistant TB (MDR-TB) within four hours.
Read MoreNew Guidelines Prefer Blood Tests to Diagnose Tuberculosis Infection in Certain Populations
Today the United States Centers for Disease Control and Prevention (CDC) issued new and important guidelines on the detection of Mycobacterium tuberculosis infections, the causative agent of tuberculosis (TB).
Read MoreNew BD BACTEC MGIT 320 System Expands TB Detection Worldwide
BD Diagnostics announced the launch of the BD BACTEC MGIT 320 Mycobacteria Culture Systema new, smaller capacity system to quickly and accurately detect tuberculosis (TB).
Read More